China’s biologics market continues to aggressively expand and achieve greater heights – regulatory reforms, new investments into the biopharma sector, more international partnerships coming into place and local biopharmas looking to go global. Product innovation and investment opportunities are in abundance as China leads the way as the 2nd largest biologics market in the world.
With numerous shifts on the horizon, the Chinese industry approaches a tipping point as companies reevaluate current trends and strategies to achieve commercial excellence. The 6th iteration of BDP Week will address the 2020 investment climate, technological advancements, industry case studies, and partnerships and expansion opportunities across key value chains.
With improved networking windows and elevated exhibition platforms, join us as the industry convenes at this highly anticipated annual gathering of biopharma leaders.